Singaporean startup Gero, originally from Russia, raised $6 million to seek new methods of treating age-related diseases. Melnichek Investments, created in July by Yuri and Anna Melnichek, invested in the company; This is the first investment by an investment company.
Singapore biotech startup Gero, founded by immigrants from Russia, has raised $6 million in Series A investments. The company specializes in finding new methods to treat chronic and age-related diseases.
The round was led by the Cypriot investment company Melnichek Investments, for which, according to Crunchbase, it is the first investment. The company was founded in July 2023 by Yuri and Anna Melnichek.
Gero collects human big data (including medical histories and genomics) and applies machine learning and artificial intelligence to understand the root causes of human aging. The project team works with experts in the field of aging biology and clinical medicine and collaborates with Pfizer.
In August 2020, Gero raised $2.2 million from Yuri Melnichek’s venture fund Bulba Ventures. Melnichek himself later joined the startup’s board of directors.
Gero was founded in 2015 by Petr Fedichev, Maxim Kholin and Igor Mikhnenko. From 2019 to 2023, Gero had three investment rounds, according to Crunchbase.
Author:
Kirill Bilyk
Source: RB
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
